KAH
HSTO

Kathryn A. Hall’s Histogen Inc. Common Stock HSTO Stock Holding History

Kathryn A. Hall’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-157
Closed -$166K – 8
2016
Q4 		$166K Buy
+157
New +$71.3K 0.2% 6

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

Kathryn A. Hall's HSTO Position: Q1 2017 in Review

Kathryn A. Hall sold out of Histogen Inc. Common Stock (HSTO) in Q1 2017, closing a stake of 157 shares — an estimated $166K sold.

Kathryn A. Hall first reported a position in HSTO in Q4 2016 and held it in 1 quarter. The position peaked at $166K in Q4 2016. 43 funds tracked by Wall St. Rank hold HSTO as of Q1 2017.

  • Kathryn A. Hall reported no remaining Histogen Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Kathryn A. Hall sold 157 Histogen Inc. Common Stock shares in Q1 2017, an estimated $166K.
  • Kathryn A. Hall first reported a position in Histogen Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • Kathryn A. Hall's Histogen Inc. Common Stock position peaked at $166K in Q4 2016.
  • 43 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2017.

Based on Kathryn A. Hall's 13F filing for Q1 2017, filed 12 May 2017.